The largest database of trusted experimental protocols

Mtt assay

Manufactured by Biotium
Sourced in United States

The MTT assay is a colorimetric technique used to measure the metabolic activity of cells. It involves the reduction of the tetrazolium dye MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to a purple formazan product by metabolically active cells. The intensity of the formazan color is directly proportional to the number of viable cells, making the MTT assay a useful tool for assessing cell proliferation, cytotoxicity, and cell viability.

Automatically generated - may contain errors

11 protocols using mtt assay

1

Inhibiting HIV-1 Entry and Replication

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, we determined the nontoxic concentrations of the pharmacologic agents used in this study in polarized epithelial cells using an MTT assay (Biotium). For inhibition of HIV-1 entry, polarized cells were pretreated for 1 h with nontoxic concentrations of chlorpromazine (10 μM), nystatin (12 μg/ml) and 5 (N-ethyl-N-isopropyl) amiloride (100 μM) (all from Sigma). Cells were then washed, and HIV-1SF33 was added to the AP surface of epithelial cells.
For inhibition of HIV-1 replication, cells were treated with 10 μM AZT for 24 h. Cells were exposed to HIV-1 and maintained with AZT for 6 days. For inhibition of MVB formation, cells were treated with LY294002 and/or GW4869 at 5 μM for 24 h and at 1 μM for the next 48 h. For inhibition of acidification of intravesicular compartments, cells were treated with 10, 20 or 30 mM NH4Cl for 2 h, and then cells were washed and HIV-1SF33 was added to the AP surface. Cells were cultured for 2 days with 10, 20 or 30 mM NH4Cl, and intracellular HIV-1 was examined by ELISA p24. The absence of a toxic effect was confirmed for all treatments by using an MTT assay (Biotium).
+ Open protocol
+ Expand
2

Inhibiting HIV-1 Entry and Replication

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, we determined the nontoxic concentrations of the pharmacologic agents used in this study in polarized epithelial cells using an MTT assay (Biotium). For inhibition of HIV-1 entry, polarized cells were pretreated for 1 h with nontoxic concentrations of chlorpromazine (10 μM), nystatin (12 μg/ml) and 5 (N-ethyl-N-isopropyl) amiloride (100 μM) (all from Sigma). Cells were then washed, and HIV-1SF33 was added to the AP surface of epithelial cells.
For inhibition of HIV-1 replication, cells were treated with 10 μM AZT for 24 h. Cells were exposed to HIV-1 and maintained with AZT for 6 days. For inhibition of MVB formation, cells were treated with LY294002 and/or GW4869 at 5 μM for 24 h and at 1 μM for the next 48 h. For inhibition of acidification of intravesicular compartments, cells were treated with 10, 20 or 30 mM NH4Cl for 2 h, and then cells were washed and HIV-1SF33 was added to the AP surface. Cells were cultured for 2 days with 10, 20 or 30 mM NH4Cl, and intracellular HIV-1 was examined by ELISA p24. The absence of a toxic effect was confirmed for all treatments by using an MTT assay (Biotium).
+ Open protocol
+ Expand
3

MTT Assay for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
SC and LSC viabilities after 72-hour treatment with MMC or 5-FU were assessed with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Biotium, Fremont, CA, USA) according to the manufacturer’s protocol, as previously described.20 (link) Optical density was quantified with a SpectraMax MiniMax 300 Imaging Cytometer (Molecular Devices, San Jose, CA, USA) at 570 nm, and background absorbance was measured at 630 nm. Quadruplicate readings were recorded. Values were normalized to the untreated control. The half-maximal effective doses (EC50) on cell viability were determined with Combenefit software.22 (link)
+ Open protocol
+ Expand
4

Proliferation of PDLSCs with PPi

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PDLSCs were gift from Dr. Songtao Shi, and the PDLSCs were characterized as reported previously.15 Cells (passage 3–5) were thawed and seeded into a 75 cm2 culture flask and cultured with a complete medium containing minimum essential medium α (α-MEM) with 10% fetal bovine serum and 1% penicillin-streptomycin. To test the effect of PPi on PDLSC proliferation, the PDLSCs were seeded at a density of 1000 cells/well in a 96-well plate. Three groups were divided according to the PPi (p8010, Sigma-Aldrich) concentrations (0, 10, and 100 μM). The cell proliferation was determined by an MTT assay (30006, Biotium) according to the manufacturer's instruction. In brief, cells were incubated with 100 μL α-MEM containing 10 μL MTT solution for 4 h at 37°C and then dissolved by 200 μL dimethyl sulfoxide (DMSO) (D2650, Sigma-Aldrich). The absorbance was measured at a wavelength of 570 nm with a microplate reader (SpectraMax 250) at the baseline of 630 nm.
+ Open protocol
+ Expand
5

Bimatoprost Influences OASC Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
OASCs from healthy controls were seeded at a density of 5 × 103 cells/well in 96-well plates in 100 μL media. After 24 hours, OASCs were treated with bimatoprost (0.25–10 μM) (Selleckchem Catalog No.S1407; Selleckchem, Houston, TX, USA) for 72 hours. After treatment, 3-(4, 5-dimethylthiazol- 2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay (Biotium, Fremont, CA, USA) was performed according to the manufacturer's instructions to measure the mitochondrial metabolism rate as a surrogate indicator for proliferation and viability. Briefly, MTT (5 mg/mL) was added and plates were incubated at 37°C for 4 hours before dimethyl sulfoxide (DMSO; 100 μL) was added to each well. Finally, the absorbance of each well was read at a wavelength of 570 nm using a scanning multiwell spectrophotometer. The results were analyzed using statistical methods in three independent experiments.
+ Open protocol
+ Expand
6

Mitomycin-C Cytotoxicity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at a density of 10,000 cells per well in a 96-well tissue culture plate with culture medium. Once the cells reached 80% confluence, they were treated with various concentrations of mitomycin-C (1.5625–100 µM) for 72 hours and maintained at 37°C in humidified 5% CO2. Normal saline solution was used as the vehicle control. Cell viability was assessed using the MTT assay (Biotium). The intensity of the dissolved formazan crystals was quantified with a SpectraMax MiniMax 300 Imaging Cytometer (Molecular Devices) at 570 nm. Background absorbance was measured at 630 nm. Quadruplicate readings were recorded.
+ Open protocol
+ Expand
7

Evaluating HeLa Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the effect of different Hex carrier proteins and endocytosis inhibitors on viability of HeLa cells, we used an MTT assay (Biotium) for measuring cell metabolic activity as an indicator of cell viability. After incubating cells with protein carriers for 24 hours or endocytosis inhibitors for 1 hour, MTT assay was conducted following manufacturer’s instructions. Absorbance at 570 nm and 630 nm of cell samples was measured by a Synergy 2 plate reader (Biotek). Background absorbance of 630 nm was subtracted from each well and all samples were normalized to the PBS-treated cells to calculate % metabolic activity. To determine the difference in fluorescence of muGFP-Hex and sfGFP-Hex, samples were diluted to various concentrations and fluorescence was analyzed with an excitation wavelength of 488 nm and an emission wavelength of 525 nm, using a Synergy 2 plate reader (Biotek).
+ Open protocol
+ Expand
8

ATO Sensitivity Assay in Malignant Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro sensitivity of the malignant cell lines toward ATO was determined at 48 h using MTT assay (Biotium, Inc., CA, USA) as described previously (24 (link)). All experiments were done in triplicates and the half-maximal inhibitory concentration (IC50) values were generated using Graph Pad Prism V6 software (La Jolla, CA, USA).
+ Open protocol
+ Expand
9

Cytotoxicity of Dental Material on Gingival Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture. Human gingival fibroblasts (HGFs) were kindly donated by Dr. Higinio Arzate's laboratory at the Autonomous National University of Mexico. HGFs were grown in DMEM supplemented with 10% fetal bovine serum (Gibco-Invitrogen, Carlsbad, California, USA), 100 U/mL penicillin, 100 µg/mL streptomycin, and 2.5 µg/ mL amphotericin at 37°C with 5% CO 2 . 25 HGF were maintained until reaching confluency.
Cytotoxicity assay. The cytotoxicity on HGFs was analyzed with the MTT cell viability assay. Hereto, 1 × 10 5 cells/100 µL were cultured in a 96-well plate of which the wells had been coated with a layer (~35 mg) of AH Plus alone or supplemented with 10 or 50 µM BisBAL NP. After a 24-h exposure, the MTT assay was performed according to the provider's instructions (Biotium, Hayward, California, USA). Non-coated wells served as a growth control. Additional non-coated controls were incubations with 10 and 50 µM BisBAL NP, and 2.5% sodium hypochlorite. The absorbance at 570 nm (A 570 ) was measured with a microplate reader (BioTek, Winooski, VT, USA).
+ Open protocol
+ Expand
10

Nanoparticle-labeled hMSC Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poietic human mesenchymal stem cells (hMSCs; Lonza, PT-2501) were grown in supplemented media (Lonza, PT-3001) and seeded in a T75 flask at a concentration of 5000 cells/cm2. These cells were labeled with nanoparticles and incubated under standard conditions. The hMSCs were washed three times with PBS to remove free nanoparticles and detached using TrypLE Express (Life Technologies). Cell viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide for the MTT assay (Biotium). Then, 10 μL of MTT solution was added to 100 μL of medium in each well, mixed briefly, and incubated at 37 °C for 4 h. Then, 200 μL of DMSO was added to each well and pipetted to dissolve the resulting formazan salt. Absorbance was measured to 570 nm. The MTT assays were conducted by plating 8000 cells per well in replicate (n = 8) in a 96 well plate and treated at varying timepoints (0–24 h) at a constant concentration (0.42 mg/mL) as well as at varying concentrations (0–0.84 mg/mL) at a constant time (4 h) unless otherwise noted. The wells were analyzed in replicate (n = 8).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!